### Comment:
It could be, but there’s nothing out there yet with regards to a buyout. They also have a legal case about a generic drug, I believe. And, yeah, I’ll be holding my January calls and stocks, but I don’t have much faith in a catalyst to change this trend any time soon.

### REPLY:
Screw it I bought more. Let's see some of the confirmation bias.

### END.